AMLX
Price
$14.59
Change
+$0.68 (+4.89%)
Updated
Jun 12 closing price
Capitalization
1.62B
53 days until earnings call
Intraday BUY SELL Signals
INDV
Price
$38.48
Change
+$0.35 (+0.92%)
Updated
Jun 12 closing price
Capitalization
4.55B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMLX vs INDV

Header iconAMLX vs INDV Comparison
Open Charts AMLX vs INDVBanner chart's image
AMLX vs INDV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AMLX vs. INDV commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and INDV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2026
Stock price -- (AMLX: $14.59 vs. INDV: $38.48)
Brand notoriety: AMLX and INDV are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMLX: 145% vs. INDV: 32%
Market capitalization -- AMLX: $1.62B vs. INDV: $4.55B
AMLX [@Pharmaceuticals: Generic] is valued at $1.62B. INDV’s [@Pharmaceuticals: Generic] market capitalization is $4.55B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileINDV’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • INDV’s FA Score: 1 green, 4 red.
According to our system of comparison, INDV is a better buy in the long-term than AMLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 5 TA indicator(s) are bullish while INDV’s TA Score has 6 bullish TA indicator(s).

  • AMLX’s TA Score: 5 bullish, 5 bearish.
  • INDV’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, INDV is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Pharmaceuticals: Generic) experienced а +9.53% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +2.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.56%. For the same industry, the average monthly price growth was +23.25%, and the average quarterly price growth was +9.77%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 06, 2026.

INDV is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.56% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INDV($4.55B) has a higher market cap than AMLX($1.62B). INDV has higher P/E ratio than AMLX: INDV (19.73) vs AMLX (2.69). AMLX YTD gains are higher at: 20.778 vs. INDV (7.246). INDV has higher annual earnings (EBITDA): 354M vs. AMLX (-158.8M). AMLX has more cash in the bank: 280M vs. INDV (175M). AMLX has less debt than INDV: AMLX (5.63M) vs INDV (509M). INDV has higher revenues than AMLX: INDV (1.29B) vs AMLX (0).
AMLXINDVAMLX / INDV
Capitalization1.62B4.55B36%
EBITDA-158.8M354M-45%
Gain YTD20.7787.246287%
P/E Ratio2.6919.7314%
Revenue01.29B-
Total Cash280M175M160%
Total Debt5.63M509M1%
FUNDAMENTALS RATINGS
INDV: Fundamental Ratings
INDV
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
65
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
73
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXINDV
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 3 days ago
57%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 13 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signal:
Gain/Loss:
INDV
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FDEM36.890.08
+0.22%
Fidelity Emerging Markets Mltfct ETF
XLG61.320.06
+0.10%
Invesco S&P 500® Top 50 ETF
MHY25.530.01
+0.02%
Man Active High Yield ETF
TMDV49.37N/A
N/A
ProShares Russell US Dividend Grwr ETF
APLY11.90-0.12
-1.00%
YieldMax AAPL Option Income Strategy ETF

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+4.89%
XOMAO - AMLX
68%
Closely correlated
+0.16%
XOMAP - AMLX
51%
Loosely correlated
-0.18%
OCUL - AMLX
46%
Loosely correlated
+2.76%
LRMR - AMLX
45%
Loosely correlated
-3.61%
JAZZ - AMLX
43%
Loosely correlated
-2.38%
More

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and SUPN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and SUPN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+0.92%
SUPN - INDV
30%
Poorly correlated
-2.50%
EBS - INDV
28%
Poorly correlated
-0.83%
ASRT - INDV
26%
Poorly correlated
+0.04%
ALKS - INDV
25%
Poorly correlated
-1.42%
AMLX - INDV
23%
Poorly correlated
+4.89%
More